Comparison of survival outcomes between laparoscopic surgery and abdominal surgery for radical hysterectomy as primary treatment in patients with stage IB2/IIA2 cervical cancer

被引:4
|
作者
Chen, Chunlin [1 ]
Guo, Jianxin [2 ]
Liu, Ping [1 ]
Li, Zhiqiang [1 ]
Jiang, Haixia [1 ,3 ]
Zhu, Qianyong [4 ]
Bin, Xiaonong [5 ]
Lang, Jinghe [1 ,6 ]
机构
[1] Southern Med Univ, Nanfang Hosp, Dept Obstet & Gynecol, 1838 Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China
[2] Third Mil Med Univ, Res Inst Surg, Daping Hosp, Dept Obstet & Gynecol, Chongqing, Peoples R China
[3] Nanchong Cent Hosp, Clin Med Coll 2, North Sichuan Med Coll, Dept Obstet & Gynecol, Nanchong, Sichuan, Peoples R China
[4] Henan Prov Peoples Hosp, Dept Obstet & Gynecol, Zhengzhou, Henan, Peoples R China
[5] Guangzhou Med Univ, Dept Epidemiol, Coll Publ Hlth, Guangzhou, Guangdong, Peoples R China
[6] Dept Obstet & Gynecol, Beijing, Peoples R China
关键词
abdominal radical hysterectomy; cervical cancer; laparoscopic radical hysterectomy; oncological outcome; RADIATION-THERAPY; RANDOMIZED-TRIAL; IB2; IIA2; CARCINOMA; LYMPHADENECTOMY;
D O I
10.1111/jog.14693
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To investigate the long-term oncological outcomes of laparoscopic radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) for the treatment of stage IB2/IIA2 cervical cancer without preoperative adjuvant therapy. Methods: We conducted a multicenter, retrospective, case-matching study. The differences in overall survival (OS) and disease-free survival (DFS) between the LRH and ARH were compared under the conditions of real-world study and case-control matching (1:1 matching). Results: There was no significant difference in the outcomes of LRH (n = 580) and ARH (n = 1653) in 5-year OS and DFS (OS: 80.6% vs. 86.1%, p = 0.421; DFS: 78.6% vs. 80.7%, p = 0.376). After 1:1 matching, there was no difference in 5-year OS and DFS between LRH (n = 554) and ARH (n = 554) (OS: 80.4% vs. 84.5%, p = 0.993; DFS: 79.0% vs. 78.8%, p = 0.695). Before and after matching, the surgical approach was not an independent risk factor for 5-year OS and DFS, and postoperative adjuvant therapy affected patient prognosis. Further subgroup analysis suggested that there was no difference in LRH (n = 313) and ARH (n = 1092) in 5-year OS or DFS in patients who underwent standard postoperative adjuvant therapy (OS: 83.0% vs. 87.7%, p = 0.992; DFS: 79.0% vs. 82.5%, p = 0.323). After 1:1 pairing, the 5-year OS and DFS in LRH (n = 295) and ARH (n = 295) showed no difference. Before and after matching, the surgical approach was not an independent risk factor affecting the 5-year OS and DFS. Conclusions: There was no difference in the oncological outcomes between laparoscopic and abdominal surgery in patients with stage IB2/IIA2 cervical cancer without preoperative adjuvant therapy. Clinical Trials: The ethical approval number is NFEC-2017-135, and the clinical research registration number is CHiCTR1800017778 (International Clinical Trials Registry Platform Search Port (http://apps.who.int/trialsearch/)
引用
收藏
页码:1516 / 1526
页数:11
相关论文
共 50 条
  • [1] Laparoscopic versus open radical hysterectomy in patients with stage IB2 and IIA2 cervical cancer
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (01) : 63 - 69
  • [2] Comparison of radical hysterectomy with chemoradiation therapy for stage IB2 and IIA2 cervical cancer
    Park, J.
    Kim, J.
    Park, S.
    Nam, J.
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S19 - S20
  • [3] Results of radical surgery in women with stage IB2/IIA2 cervical cancer
    Derks, Marloes
    Biewenga, Petra
    van der Velden, Jacobus
    Kenter, Gemma G.
    Stalpers, Lukas J. A.
    Buist, Marrije R.
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2016, 95 (02) : 166 - 172
  • [4] Radical surgery for stage IB2/IIA2 cervical cancer: A large retrospective study
    Zhou, Fang
    Tang, Xuedong
    Shao, Zhuyan
    Chen, Xi
    Gao, Wen
    Fang, Chenyan
    Wang, Zejia
    Zhang, Ping
    Zhu, Tao
    Tang, Huarong
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [5] A Single-Institution Radical Surgery Results in Stage IB2/IIA2 (Bulky) Cervical Cancer
    Khatib, Ghanim
    Gulec, Umran Kucukgoz
    Guzel, Ahmet Baris
    Uygur, Berk
    Seydaoglu, Gulsah
    Gumurdulu, Derya
    Vardar, Mehmet Ali
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (08) : 1480 - 1484
  • [6] Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer
    Kim, Se Ik
    Cho, Jae Hyun
    Seol, Aeran
    Kim, Young Im
    Lee, Maria
    Kim, Hee Seung
    Chung, Hyun Hoon
    Kim, Jae-Weon
    Park, Noh Hyun
    Song, Yong-Sang
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 153 (01) : 3 - 12
  • [7] Adjuvant hysterectomy following primary chemoradiation for stage IB2 and IIA2 cervical cancer: A comparison of complications for open versus minimally invasive surgery
    Miller, H.
    Hom, M. S.
    Castaneda, A.
    Matsuo, K.
    Roman, L. D.
    Brunette, L. L.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 202 - 202
  • [8] Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Kim, Young-Seok
    Kim, Ha Jeong
    Lee, Jeong-Won
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Huh, Seung Jae
    Nam, Joo-Hyun
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2012, 23 (04) : 226 - 234
  • [9] Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer
    Yuhui Huang
    Lei Chen
    Jing Cai
    Lu Yang
    Si Sun
    Jing Zhao
    Zhoufang Xiong
    Zehua Wang
    [J]. World Journal of Surgical Oncology, 20
  • [10] Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer
    Huang, Yuhui
    Chen, Lei
    Cai, Jing
    Yang, Lu
    Sun, Si
    Zhao, Jing
    Xiong, Zhoufang
    Wang, Zehua
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)